Senescence-Resistant Human Mesenchymal Progenitor Cells Counter Aging in Primates

In a 44-week trial, scientists intravenously delivered senescence-resistant human mesenchymal progenitor cells to aged macaques, noting a systemic reduction in aging indicators, such as cellular senescence, chronic inflammation, and tissue degeneration, without any detected adverse effects.